Published in Health Risk Factor Week, February 20th, 2007
This trend article about St. George Hospital, Kogarah, Australia, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: New research, "Evaluation of urokinase plasminogen activator and its receptor in different grades of human prostate cancer," is the subject of a report. According to recent research from Kogarah, Australia, "Increased expression of urokinase plasminogen activator (uPA) and its receptor (uPAR) has been reported in various malignancies including prostate cancer (CaP). However, their expression in the different...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.